Search the Newsreel

Walleye Capital LLC Makes New $3.95 Million Investment in JBT Marel Corporation $JBTM

Walleye Capital LLC has made a new investment of $3.95 million in JBT Marel Corporation, purchasing 27,265 shares. Institutional investors collectively own 98.92% of the company, which recently reported Q2 EPS of $1.95, missing consensus estimates, and declared a quarterly dividend of $0.10 per …

Relx Plc Aktie • A0M95J • GB00B2B0DG97

Cornerstone Capital Inc. Buys Shares of 63,505 Reliance, Inc. $RS

Cornerstone Capital Inc. has acquired 63,505 shares of Reliance, Inc. (NYSE:RS), valued at approximately $23.7 million, making it a significant portion of their portfolio. Reliance recently reported strong quarterly earnings, beating estimates and showing substantial revenue growth, and also declared a quarterly dividend. Despite …

Perella Weinberg Partners (PWP) Q4 2024 Earnings Report - Results, Call & Slides

G-III Apparel Group (NASDAQ:GIII) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded G-III Apparel Group (NASDAQ:GIII) from a "buy" to a "hold" rating, aligning with the overall average "Hold" rating and a $33.00 price target from other analysts. Despite this, G-III Apparel Group exceeded quarterly earnings and revenue expectations, reporting an …

Relay Therapeutics (NASDAQ:RLAY) Rating Lowered to "Sell" at Wall Street Zen

Wall Street Zen has downgraded Relay Therapeutics (NASDAQ:RLAY) from a "Hold" to a "Sell" rating, despite the broader analyst consensus remaining a "Moderate Buy" with an average price target of $25.83. This downgrade follows the company's recent quarterly earnings report, where it missed both …

Reliance (NYSE:RS) Rating Lowered to "Buy" at Wall Street Zen

Wall Street Zen has downgraded Reliance (NYSE:RS) from a "strong buy" to a "buy" rating, despite the company reporting stronger-than-expected quarterly results with EPS of $6.27 and revenue of $4.63 billion. While the broader analyst consensus remains "hold" with an average price target of …

Tidewater Renewables (TSX:LCFS) Stock Price Faces Earnings Quality Questions

PERCEPTIVE ADVISORS LLC Expands Relay Therapeutics Inc (RLAY) Stake -- Shares Look 421% Overvalued on GF Value

Perceptive Advisors LLC significantly increased its stake in Relay Therapeutics Inc (RLAY) by purchasing 13.67 million shares, bringing their total ownership to 6.40%. Despite this strong conviction from a specialized healthcare investment firm, GuruFocus identifies RLAY shares as "Significantly Overvalued" by 421% based on …

RCOM Share Price Today - Reliance Communications on NSE/BSE

Relay Therapeutics (RLAY): Commodore Capital group discloses 12M-share, 5.5% position

Commodore Capital LP and its affiliates, including Commodore Capital Master LP, Robert Egen Atkinson, and Michael Kramarz, have disclosed a beneficial ownership of 12,000,000 shares of Relay Therapeutics, Inc. (RLAY) common stock. This stake represents 5.5% of the outstanding common stock, based on 218,531,200 …

Cyrela (CYRE3) tem pouco espaço para crescimento de margem bruta sobre patamar atual, diz CFO

Relmada Therapeutics (RLMD) gains 7.0% shareholder position from Squadron funds

Investment entities affiliated with Squadron Capital Management LLC have reported a beneficial ownership of 7.0% in Relmada Therapeutics, Inc. This stake, amounting to 7,350,000 shares, is held by Squadron Master Fund LP, Squadron Capital Management LLC, Matthew Sesterhenn, and William Blank, based on shares …

Relay Therapeutics (NASDAQ:RLAY) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Cracker Barrel (CBRL) holder GMT Capital discloses 2.44% beneficial stake

GMT Capital Corp. and its control person Thomas E. Claugus have disclosed a 2.44% beneficial stake in Cracker Barrel Old Country Store, Inc. This ownership, totaling 545,200 shares, is held through various managed funds and accounts, with shared voting and dispositive power. The filing …

Religare Strengthens Earnings Momentum

T. Rowe Price (NASDAQ: AMBA) discloses 5.9% Ambarella ownership in Schedule 13G

T. Rowe Price Associates, Inc. has filed a Schedule 13G, disclosing a beneficial ownership of 2,598,863 shares of Ambarella Inc. common stock, which represents 5.9% of the class. The filing indicates that T. Rowe Price has sole voting power over 2,595,519 shares and sole …

Estrella Immunopharma (ESLA): Armistice Capital discloses 4.99% ownership stake

Armistice Capital, LLC and Steven Boyd have disclosed a 4.99% beneficial ownership stake in Estrella Immunopharma, Inc. (ESLA) common stock. This translates to 2,051,409 shares, over which they hold shared voting and dispositive power. The shares are held by Armistice Capital Master Fund Ltd., …

Reliable Ventures India Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

RELX climbs Friday, outperforms market

Shares of RELX PLC (REL) rose by 1.41% on Friday to £25.26, outperforming the broader market. This occurred during a difficult trading session where the FTSE 100 Index (UKX) fell by 0.21%. Despite the day's gain, RELX PLC's stock closed 30.49% below its 52-week …

Reliance Power Ltd Dividend History, Yield & Record Date

Relaxo Footwears Q1FY27 net profit up 12% to ₹549 crore

Handelsbanken Fonder AB Sells 262,293 Shares of Ambarella, Inc. $AMBA

Handelsbanken Fonder AB significantly reduced its stake in Ambarella, Inc. by selling 262,293 shares, retaining 134,397 shares valued at $11.5 million. Despite this reduction, institutional investors still hold 82.09% of the company, and analysts generally maintain a "Moderate Buy" rating with a consensus price …

Reliance Steel closes 0.2% below its yearly high as valuation stretch becomes the cleaner risk

RS gained 4.4% for the week and is up 17.6% over 12 weeks, but the move came on average volume while the stock trades 43.2% above Sharemaestro Fair Value.

Reliance Home Finance Ltd (RHFL) Share Price

Relaxo Footwears standalone net profit rises 12.35% in the June 2026 quarter

Estrella Immunopharma, Inc. 2Q 2026: Net loss $(2.31M), EPS $(0.05) — 10-Q Summary

Estrella Immunopharma, Inc. reported a net loss of $(2.31M) for the second quarter of 2026, with a loss per share of $(0.05). The company remains pre-revenue, driven by ongoing development and corporate expenses. Key highlights include progress in clinical trials, significant milestones in a …

Ambarella, Inc. (0YU1.L) Analyst insights, Price targets and Recommendations

This article provides an overview of analyst ratings for Ambarella, Inc. (0YU1.L), including recent upgrades and downgrades from firms like B of A Securities, Susquehanna, and Rosenblatt. It lists various "Maintains" ratings, indicating that analysts reaffirmed their previous stances on the stock, mostly positive …

Relay Therapeutics Stock Is Up Nearly 500% Over the Past Year

Relay Therapeutics (RLAY), a clinical-stage precision medicines company in targeted oncology with a $4.4 billion market cap, has seen its stock surge by 486% over the past year, trading near a new 3-year high. While technical momentum is strong with a 100% "Buy" opinion …

Is Reliance, Inc. (RS) Stock Outpacing Its Basic Materials Peers This Year?

Investors interested in Basic Materials stocks should always be looking to find the best-performing companies in the group. Has Reliance (RS) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Basic Materials peers, …

RELX falls Thursday, underperforms market

Shares of RELX PLC (REL) dropped 1.97% on Thursday, closing at £24.91, underperforming the FTSE 100 Index which fell 0.56%. The company's stock is now 31.45% below its 52-week high of £36.34, reached on August 20th. This decline occurred during a generally poor trading …

Reliance, Inc. $RS Shares Sold by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC reduced its stake in Reliance, Inc. (NYSE:RS) by 21.9% in Q2, selling 5,064 shares but retaining 18,026 shares valued at $6.7 million. Despite institutional investors owning 79.26% of the company and a strong Q2 earnings beat, analysts …

Perella Weinberg Partners $PWP Shares Sold by Wasatch Advisors LP